J
Jeffrey Gornbein
Researcher at University of California, Los Angeles
Publications - 175
Citations - 16813
Jeffrey Gornbein is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 50, co-authored 160 publications receiving 15236 citations.
Papers
More filters
Journal ArticleDOI
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Jeffrey L. Cummings,Michael S. Mega,Kevin F. Gray,S. Rosenberg-Thompson,Daniela Carusi,Jeffrey Gornbein +5 more
TL;DR: The NPI has the advantages of evaluating a wider range of psychopathology than existing instruments, soliciting information that may distinguish among different etiologies of dementia, differentiating between severity and frequency of behavioral changes, and minimizing administration time.
Journal ArticleDOI
A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke
Chelsea S. Kidwell,Reza Jahan,Jeffrey Gornbein,Jeffry R. Alger,Val Nenov,Zahra Ajani,Lei Feng,Brett C. Meyer,Scott E Olson,Scott E Olson,Lee H. Schwamm,Albert J Yoo,Randolph S. Marshall,Philip M. Meyers,Dileep R. Yavagal,Max Wintermark,Judy Guzy,Sidney Starkman,Jeffrey L. Saver +18 more
TL;DR: A favorable penumbral pattern on neuroimaging did not identify patients who would differentially benefit from endovascular therapy for acute ischemic stroke, nor was embolectomy shown to be superior to standard care.
Journal ArticleDOI
The spectrum of behavioral changes in Alzheimer's disease
TL;DR: Agitation, dysphoria, apathy, and aberrant motor behavior were significantly correlated with cognitive impairment in patients with Alzheimer's disease compared with normal age-matched control subjects.
Journal ArticleDOI
A search for serologic correlates of immunity to Bordetella pertussis cough illnesses
TL;DR: The data support historical data indicating that agglutinating antibodies are associated with protection and also recent serologic correlates data and clinical efficacy data which indicate that multicomponent vaccines containing pertactin and fimbriae have better efficacy than PT or PT/FHA vaccines.
Journal ArticleDOI
Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review
TL;DR: The authors in this paper determined the prior prevalence of Barrett's esophagus in reported cases of incident adenocarcinoma undergoing resection, as an indirect measure of impact.